» Articles » PMID: 22772752

Regulation of Lymphocyte Function by Adenosine

Overview
Date 2012 Jul 10
PMID 22772752
Citations 77
Authors
Affiliations
Soon will be listed here.
Abstract

Adenosine regulates the interaction between lymphocytes and the vasculature, and is important for controlling lymphocyte trafficking in response to tissue injury or infection. Adenosine can blunt the effects of T cell receptor activation primarily by activating adenosine A(2A) receptors and signaling via cyclic AMP and protein kinase A. Protein kinase A reduces proximal T cell receptor signaling by phosphorylation of C-terminal Src kinase, nuclear factor of activated T cells and cyclic AMP response element-binding protein. Protein kinase A activation can either enhance or inhibit the survival of T cells depending on the strength and duration of signaling. Inducible enzymes such as CD73 and CD39 regulate adenosine formation and degradation in vivo. The extravasation of lymphocytes through blood vessels is influenced by A(2A) receptors-mediated suppression of intercellular adhesion molecule 1 expression on lymphocytes and diminished production of interferon γ and interferon γ-inducible chemokines that are chemotactic to activated lymphocytes. Adenosine also decreases the barrier function of vascular endothelium by activating A(2B)Rs. In sum, adenosine signaling is influenced by tissue inflammation and injury through induction of receptors and enzymes and has generally inhibitory effects on lymphocyte migration into inflamed tissues due to protein kinase A-mediated effects on adhesion molecules, interferon γ production, and endothelial barrier function.

Citing Articles

Mesenchymal Stem/Stromal Cells Derived from Dental Tissues Mediate the Immunoregulation of T Cells through the Purinergic Pathway.

Poblano-Perez L, Monroy-Garcia A, Fragoso-Gonzalez G, Mora-Garcia M, Castell-Rodriguez A, Mayani H Int J Mol Sci. 2024; 25(17).

PMID: 39273524 PMC: 11395442. DOI: 10.3390/ijms25179578.


Ablation of impairs metabolic reprogramming and proliferation of T lymphocytes and compromises mouse survival.

Romero-Carraminana I, Dominguez-Zorita S, Esparza-Molto P, Cuezva J iScience. 2024; 27(6):109863.

PMID: 38799559 PMC: 11126974. DOI: 10.1016/j.isci.2024.109863.


Purinergic enzymes on extracellular vesicles: immune modulation on the go.

Winzer R, Nguyen D, Schoppmeier F, Cortesi F, Gagliani N, Tolosa E Front Immunol. 2024; 15:1362996.

PMID: 38426088 PMC: 10902224. DOI: 10.3389/fimmu.2024.1362996.


Analysis of Metabolites in Gout: A Systematic Review and Meta-Analysis.

Li Y, Han X, Tong J, Wang Y, Liu X, Liao Z Nutrients. 2023; 15(14).

PMID: 37513561 PMC: 10383779. DOI: 10.3390/nu15143143.


Roles of Adenosine Receptor (subtypes A and A) in Cuprizone-Induced Hippocampal Demyelination.

Adebiyi O, Bynoe M Mol Neurobiol. 2023; 60(10):5878-5890.

PMID: 37358743 DOI: 10.1007/s12035-023-03440-6.


References
1.
Ohnuma K, Dang N, Morimoto C . Revisiting an old acquaintance: CD26 and its molecular mechanisms in T cell function. Trends Immunol. 2008; 29(6):295-301. DOI: 10.1016/j.it.2008.02.010. View

2.
Hasko G, Kuhel D, Chen J, Schwarzschild M, Deitch E, Mabley J . Adenosine inhibits IL-12 and TNF-[alpha] production via adenosine A2a receptor-dependent and independent mechanisms. FASEB J. 2000; 14(13):2065-74. DOI: 10.1096/fj.99-0508com. View

3.
Wallace K, Marshall M, Ramos S, Lannigan J, Field J, Strieter R . NKT cells mediate pulmonary inflammation and dysfunction in murine sickle cell disease through production of IFN-gamma and CXCR3 chemokines. Blood. 2009; 114(3):667-76. PMC: 2713467. DOI: 10.1182/blood-2009-02-205492. View

4.
Li K, Anderson K, Peng Q, Noble A, Lu B, Kelly A . Cyclic AMP plays a critical role in C3a-receptor-mediated regulation of dendritic cells in antigen uptake and T-cell stimulation. Blood. 2008; 112(13):5084-94. DOI: 10.1182/blood-2008-05-156646. View

5.
Ohta A, Ohta A, Madasu M, Kini R, Subramanian M, Goel N . A2A adenosine receptor may allow expansion of T cells lacking effector functions in extracellular adenosine-rich microenvironments. J Immunol. 2009; 183(9):5487-93. DOI: 10.4049/jimmunol.0901247. View